🔎 Trials Near Me

Utama › Limfoma Burkitt › Utah › Salt Lake City

Kajian klinikal Limfoma Burkitt di Salt Lake City, UT

7 kajian untuk Limfoma Burkitt sedang mencari peserta di lokasi dalam dan sekitar Salt Lake City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Mengambil pesertaFasa 1
  • Primary Children's Hospital, Salt Lake City
Umur 0 hingga 18 · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06173518

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Mengambil pesertaFasa 3
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Umur 18 hingga 39 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT03150693

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Mengambil pesertaFasa 1/2
  • Intermountain - Primary Children's Hospital ( Site 1014), Salt Lake City
6 Months – 25 Years · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06395103

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Mengambil pesertaFasa 2
  • Primary Children's Hospital, Salt Lake City
Umur 1 hingga 30 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Mengambil pesertaFasa 3
  • Primary Children's Hospital, Salt Lake City
365 Days – 25 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Mengambil pesertaFasa 2
  • Primary Children's Hospital, Salt Lake City
Umur 7 hingga 25 · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT05082519

Kajian Limfoma Burkitt di bandar lain

Kajian lain di Salt Lake City

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.